Optimizing Exposure Using Occasional Aversive Imagery in Spider Fearful Individuals
Optimizing Exposure Therapy Via Occasional Aversive Imagery: A Randomized Controlled Trial With Spider Fearful Individuals
1 other identifier
interventional
67
1 country
1
Brief Summary
The effectiveness of an optimized extinction training is investigated in spider-fearful individuals. Participants will undergo a one-session standardized extinction training, either with or without occasional metal imagination of most feared apprehension towards spiders. The effectiveness of the training is measured by symptom improvement according to subjective ratings and behavioural avoidance tests one week later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2022
CompletedStudy Start
First participant enrolled
June 15, 2022
CompletedFirst Posted
Study publicly available on registry
June 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedJanuary 9, 2026
January 1, 2026
1.1 years
June 14, 2022
January 7, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Spider Phobia Questionnaire (SPQ)
31-item true/false questionnaire assessing symptoms of arachnophobia. Scores range from 0 to 31, with greater scores representing greater fear of spiders. Spider phobic individuals have obtained mean scores of 23.20 (SD = 2.90) and 23.76 (SD = 3.80) on the SPQ.
Change from baseline to post-treatment (i.e., 7-9 days)
Behavioral Approach Test (BAT)
Number of test steps fully completed (0-14 steps)
Change from baseline to post-treatment (i.e., 7-9 days)
Fear rating
Maximum fear rating on a scale from 0 (no fear) to 100 (severe fear) recorded once during BAT
Change from baseline to post-treatment (i.e., 7-9 days)
Secondary Outcomes (4)
Fear of Spider Questionnaire (FSQ)
Change from baseline to post-treatment (i.e., 7-9 days)
Change in anxiety sensitivity (ASI-3)
change from baseline to post-treatment (i.e. 7-9 days)
PROMIS Emotional Distress-Anxiety-Short Form
change from baseline to post-treatment (i.e. 7-9 days)
US expectancy and fear ratings
Baseline
Study Arms (2)
Exposure + occasional aversive imagination
EXPERIMENTALrepeated imaginations of the participants' most feared apprehension during extinction training with seven standardized exposure steps
Exposure
ACTIVE COMPARATORStandard extinction training with seven standardized exposure steps
Interventions
During six of the 27 exposure trials, participants in the experimental group are asked to imagine their most feared outcome towards spiders as vividly as possible while completing the specific trial.
• All participants complete an exposure training session (approx. 75 min) with seven exposure steps, which are repeated between one and five times (e.g. Step 4: directing the spider with a pen by touching its legs at least five times per repetition; this step must be repeated five times before continuing to the next step). One repetition per step is considered one trial, therefore each participant aims to complete 27 exposure trials.
Eligibility Criteria
You may qualify if:
- Elevated score on Spider Phobia Questionnaire (SPQ) \> 17
You may not qualify if:
- Severe allergies to bees/spiders/insects
- current psychotherapeutic/psychiatric treatment
- past psychotherapeutic/psychiatric treatment due to anxiety problems
- current or past psychotic symptoms
- current suicidal intent
- experience with exposure-based treatment
- current psychopharmacological medication
- severe cardiovascular, respiratory or neurological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Philipps-University Marburg
Marburg, Hesse, 35037, Germany
Related Publications (5)
Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B. Maximizing exposure therapy: an inhibitory learning approach. Behav Res Ther. 2014 Jul;58:10-23. doi: 10.1016/j.brat.2014.04.006. Epub 2014 May 9.
PMID: 24864005BACKGROUNDCulver NC, Stevens S, Fanselow MS, Craske MG. Building physiological toughness: Some aversive events during extinction may attenuate return of fear. J Behav Ther Exp Psychiatry. 2018 Mar;58:18-28. doi: 10.1016/j.jbtep.2017.07.003. Epub 2017 Jul 25.
PMID: 28777975BACKGROUNDLipp OV, Ryan KM, Luck CC, Craske MG, Waters AM. Presentation of unpaired unconditional stimuli during extinction reduces renewal of conditional fear and slows re-acquisition. Psychophysiology. 2021 Oct;58(10):e13899. doi: 10.1111/psyp.13899. Epub 2021 Jul 6.
PMID: 34231228BACKGROUNDShiban Y, Wittmann J, Weissinger M, Muhlberger A. Gradual extinction reduces reinstatement. Front Behav Neurosci. 2015 Sep 15;9:254. doi: 10.3389/fnbeh.2015.00254. eCollection 2015.
PMID: 26441581BACKGROUNDThompson A, McEvoy PM, Lipp OV. Enhancing extinction learning: Occasional presentations of the unconditioned stimulus during extinction eliminate spontaneous recovery, but not necessarily reacquisition of fear. Behav Res Ther. 2018 Sep;108:29-39. doi: 10.1016/j.brat.2018.07.001. Epub 2018 Jul 3.
PMID: 29981936BACKGROUND
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph Benke, PhD
Philipps University Marburg
- PRINCIPAL INVESTIGATOR
Christiane Pané-Farré, PhD
Philipps University Marburg
- PRINCIPAL INVESTIGATOR
Dorothee Scheuermann, M.Sc.
Philipps University Marburg
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 14, 2022
First Posted
June 21, 2022
Study Start
June 15, 2022
Primary Completion
July 31, 2023
Study Completion
September 30, 2023
Last Updated
January 9, 2026
Record last verified: 2026-01